102 related articles for article (PubMed ID: 1461933)
21. Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling.
Frederiksen LJ; Sullivan R; Maxwell LR; Macdonald-Goodfellow SK; Adams MA; Bennett BM; Siemens DR; Graham CH
Clin Cancer Res; 2007 Apr; 13(7):2199-206. PubMed ID: 17404104
[TBL] [Abstract][Full Text] [Related]
22. Overview of tumor cell chemoresistance mechanisms.
Gatti L; Zunino F
Methods Mol Med; 2005; 111():127-48. PubMed ID: 15911977
[TBL] [Abstract][Full Text] [Related]
23. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.
Peluso G; Nicolai R; Reda E; Benatti P; Barbarisi A; Calvani M
J Cell Physiol; 2000 Mar; 182(3):339-50. PubMed ID: 10653600
[TBL] [Abstract][Full Text] [Related]
24. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ
Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940
[TBL] [Abstract][Full Text] [Related]
26. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
27. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.
O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J
Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334
[TBL] [Abstract][Full Text] [Related]
29. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
30. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
Townsend AJ; Tu CP; Cowan KH
Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
[TBL] [Abstract][Full Text] [Related]
31. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
Workman P
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
[TBL] [Abstract][Full Text] [Related]
32. Liminal therapy: a strategy for the complete and selective destruction of malignant tissue in situ.
Jones GR; Frohn MJ; Beckett AH
Med Hypotheses; 1984 Dec; 15(4):349-59. PubMed ID: 6527664
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia and drug resistance.
Teicher BA
Cancer Metastasis Rev; 1994 Jun; 13(2):139-68. PubMed ID: 7923547
[TBL] [Abstract][Full Text] [Related]
34. Successful cancer therapy with promethazine: the rationale.
Jones GR
Med Hypotheses; 1996 Jan; 46(1):25-9. PubMed ID: 8746124
[TBL] [Abstract][Full Text] [Related]
35. The role of glutathione in determining the response of normal and tumor cells to anticancer drugs.
Wolf CR; Lewis AD; Carmichael J; Adams DJ; Allan SG; Ansell DJ
Biochem Soc Trans; 1987 Aug; 15(4):728-30. PubMed ID: 3678588
[No Abstract] [Full Text] [Related]
36. Drug resistance in oncology: from concepts to applications.
Cazin JL; Gosselin P; Cappelaere P; Robert J; Demaille A
J Cancer Res Clin Oncol; 1992; 119(2):76-86. PubMed ID: 1429830
[TBL] [Abstract][Full Text] [Related]
37. [Enzyme therapy of tumors].
Kurinenko BM
Antibiot Med Biotekhnol; 1987 Aug; 32(8):604-11. PubMed ID: 3314692
[No Abstract] [Full Text] [Related]
38. [Alteration of energy metabolism of the tumors cell by Trenimon].
PUETTER J
Strahlentherapie; 1961; Suppl 48():118-26. PubMed ID: 14489149
[No Abstract] [Full Text] [Related]
39. [Cell-agar-plate method for assaying anti-tumor activity, and its application to the elucidation of the mode of action].
YAMAMOTO T; KOMEIJI T; NISHIOKA K; TAKEUCHI T; NITTA K
Gan; 1956 Dec; 47(3-4):424-7. PubMed ID: 13415067
[No Abstract] [Full Text] [Related]
40. A review: on the mechanism of action of certain temporary anti-cancer agents.
SKIPPER HE
Cancer Res; 1953 Aug; 13(8):545-51. PubMed ID: 13082484
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
